Akso Cost Of Revenue vs Total Revenue Analysis

AHG Stock

USD 1.20 0.09 8.11%

Akso Health financial indicator trend analysis is way more than just evaluating Akso Health Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akso Health Group is a good investment. Please check the relationship between Akso Health Cost Of Revenue and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Akso Health Group Cost Of Revenue account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Akso Health's Cost Of Revenue and Total Revenue is 0.59. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Akso Health Group, assuming nothing else is changed. The correlation between historical values of Akso Health's Cost Of Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Akso Health Group are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Cost Of Revenue i.e., Akso Health's Cost Of Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.59

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Akso Health Group income statement and represents the costs associated with goods and services Akso Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Revenue

Total revenue comprises all receipts Akso Health Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Akso Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akso Health Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

At this time, Akso Health's Issuance Of Capital Stock is most likely to increase significantly in the upcoming years. The Akso Health's current Enterprise Value Over EBITDA is estimated to increase to 3.93, while Sales General And Administrative To Revenue is projected to decrease to 2.06.

	2021	2022	2023	2024 (projected)
Gross Profit	916.2K	1.3M	122.1K	116.0K
Total Revenue	6.3M	13.2M	2.4M	2.3M

Gross Profit Total Revenue

Akso Health fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Tangible Assets	Non Current Liabilities Total	Net Invested Capital	Net Working Capital	Intangible Assets	Property Plant Equipment	Short Long Term Debt Total	Other Liab
Common Stock Shares Outstanding		0.37	-0.34	-0.3	0.65	-0.33	-0.53	-0.61	0.36	-0.26	-0.95	0.36	0.77	-0.12	0.96	-0.3	0.46	0.99	-0.63	-0.51	0.11	0.16	-0.94	-0.61	-0.86	-0.94
Total Assets	0.37		0.37	0.35	0.91	0.48	-0.77	0.34	0.88	0.4	-0.27	0.88	0.8	0.09	0.54	0.51	0.94	0.39	-0.15	-0.39	0.23	0.02	-0.31	0.11	-0.21	-0.31
Other Current Liab	-0.34	0.37		0.94	0.1	0.3	-0.18	0.38	0.29	0.33	0.44	0.29	0.07	-0.04	-0.19	0.83	0.3	-0.35	0.1	-0.09	-0.18	-0.3	0.35	0.22	0.22	0.35
Total Current Liabilities	-0.3	0.35	0.94		0.07	0.21	-0.15	0.23	0.28	0.26	0.36	0.28	0.08	-0.07	-0.11	0.86	0.31	-0.33	-0.12	-0.3	-0.44	-0.55	0.35	0.01	0.05	0.35
Total Stockholder Equity	0.65	0.91	0.1	0.07		0.27	-0.87	0.15	0.85	0.2	-0.55	0.85	0.89	-0.01	0.75	0.2	0.9	0.67	-0.23	-0.37	0.36	0.22	-0.64	-0.05	-0.41	-0.64
Property Plant And Equipment Net	-0.33	0.48	0.3	0.21	0.27		0.01	0.62	0.2	0.7	0.47	0.2	0.29	0.73	-0.17	0.64	0.28	-0.3	0.22	-0.12	0.11	-0.16	0.28	0.62	0.51	0.28
Net Debt	-0.53	-0.77	-0.18	-0.15	-0.87	0.01		-0.18	-0.95	0.17	0.53	-0.95	-0.65	0.26	-0.61	-0.03	-0.89	-0.56	0.11	0.08	-0.34	-0.35	0.52	0.15	0.37	0.52
Retained Earnings	-0.61	0.34	0.38	0.23	0.15	0.62	-0.18		0.32	0.55	0.67	0.32	-0.19	0.03	-0.55	0.36	0.19	-0.57	0.8	0.53	0.5	0.32	0.51	0.88	0.81	0.51
Cash	0.36	0.88	0.29	0.28	0.85	0.2	-0.95	0.32		0.0	-0.36	1.0	0.63	-0.14	0.49	0.23	0.96	0.39	-0.08	-0.14	0.25	0.19	-0.29	-0.03	-0.24	-0.29
Non Current Assets Total	-0.26	0.4	0.33	0.26	0.2	0.7	0.17	0.55	0.0		0.47	0.0	0.16	0.24	-0.2	0.63	0.08	-0.26	0.32	-0.14	0.25	-0.1	0.24	0.69	0.43	0.24
Non Currrent Assets Other	-0.95	-0.27	0.44	0.36	-0.55	0.47	0.53	0.67	-0.36	0.47		-0.36	-0.65	0.19	-0.92	0.45	-0.43	-0.96	0.65	0.45	-0.04	-0.15	0.89	0.73	0.9	0.89
Cash And Short Term Investments	0.36	0.88	0.29	0.28	0.85	0.2	-0.95	0.32	1.0	0.0	-0.36		0.63	-0.14	0.49	0.23	0.96	0.39	-0.08	-0.14	0.25	0.19	-0.29	-0.03	-0.24	-0.29
Net Receivables	0.77	0.8	0.07	0.08	0.89	0.29	-0.65	-0.19	0.63	0.16	-0.65	0.63		0.26	0.88	0.27	0.78	0.77	-0.57	-0.68	0.06	-0.07	-0.73	-0.3	-0.61	-0.73
Other Current Assets	-0.12	0.09	-0.04	-0.07	-0.01	0.73	0.26	0.03	-0.14	0.24	0.19	-0.14	0.26		0.0	0.31	0.01	-0.1	-0.19	-0.29	-0.23	-0.31	0.1	0.14	0.21	0.1
Other Stockholder Equity	0.96	0.54	-0.19	-0.11	0.75	-0.17	-0.61	-0.55	0.49	-0.2	-0.92	0.49	0.88	0.0		-0.08	0.62	0.95	-0.73	-0.67	-0.03	-0.02	-0.89	-0.64	-0.88	-0.89
Total Liab	-0.3	0.51	0.83	0.86	0.2	0.64	-0.03	0.36	0.23	0.63	0.45	0.23	0.27	0.31	-0.08		0.34	-0.32	-0.1	-0.44	-0.34	-0.59	0.33	0.25	0.18	0.33
Total Current Assets	0.46	0.94	0.3	0.31	0.9	0.28	-0.89	0.19	0.96	0.08	-0.43	0.96	0.78	0.01	0.62	0.34		0.48	-0.26	-0.36	0.14	0.04	-0.36	-0.11	-0.35	-0.36
Common Stock	0.99	0.39	-0.35	-0.33	0.67	-0.3	-0.56	-0.57	0.39	-0.26	-0.96	0.39	0.77	-0.1	0.95	-0.32	0.48		-0.58	-0.46	0.18	0.23	-0.95	-0.57	-0.83	-0.95
Net Tangible Assets	-0.63	-0.15	0.1	-0.12	-0.23	0.22	0.11	0.8	-0.08	0.32	0.65	-0.08	-0.57	-0.19	-0.73	-0.1	-0.26	-0.58		0.89	0.69	0.63	0.5	0.88	0.87	0.5
Non Current Liabilities Total	-0.51	-0.39	-0.09	-0.3	-0.37	-0.12	0.08	0.53	-0.14	-0.14	0.45	-0.14	-0.68	-0.29	-0.67	-0.44	-0.36	-0.46	0.89		0.61	0.72	0.4	0.58	0.7	0.4
Net Invested Capital	0.11	0.23	-0.18	-0.44	0.36	0.11	-0.34	0.5	0.25	0.25	-0.04	0.25	0.06	-0.23	-0.03	-0.34	0.14	0.18	0.69	0.61		0.93	-0.23	0.61	0.35	-0.23
Net Working Capital	0.16	0.02	-0.3	-0.55	0.22	-0.16	-0.35	0.32	0.19	-0.1	-0.15	0.19	-0.07	-0.31	-0.02	-0.59	0.04	0.23	0.63	0.72	0.93		-0.27	0.4	0.25	-0.27
Intangible Assets	-0.94	-0.31	0.35	0.35	-0.64	0.28	0.52	0.51	-0.29	0.24	0.89	-0.29	-0.73	0.1	-0.89	0.33	-0.36	-0.95	0.5	0.4	-0.23	-0.27		0.5	0.75	1.0
Property Plant Equipment	-0.61	0.11	0.22	0.01	-0.05	0.62	0.15	0.88	-0.03	0.69	0.73	-0.03	-0.3	0.14	-0.64	0.25	-0.11	-0.57	0.88	0.58	0.61	0.4	0.5		0.9	0.5
Short Long Term Debt Total	-0.86	-0.21	0.22	0.05	-0.41	0.51	0.37	0.81	-0.24	0.43	0.9	-0.24	-0.61	0.21	-0.88	0.18	-0.35	-0.83	0.87	0.7	0.35	0.25	0.75	0.9		0.75
Other Liab	-0.94	-0.31	0.35	0.35	-0.64	0.28	0.52	0.51	-0.29	0.24	0.89	-0.29	-0.73	0.1	-0.89	0.33	-0.36	-0.95	0.5	0.4	-0.23	-0.27	1.0	0.5	0.75

Click cells to compare fundamentals

Akso Health Account Relationship Matchups

Akso Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	16.3M	16.3M	19.9M	22.9M	47.2M	49.5M
Total Assets	78.4M	31.7M	50.7M	20.5M	142.0M	86.9M
Other Current Liab	9.3M	4.1M	38.4M	1.8M	1.1M	1.0M
Total Current Liabilities	10.2M	14.4M	38.4M	11.6M	3.6M	3.4M
Total Stockholder Equity	48.1M	17.3M	12.3M	8.7M	138.4M	145.3M
Property Plant And Equipment Net	1.3M	1.6M	66.9K	55.4K	49.9K	47.4K
Net Debt	9.9M	(5.1M)	(21.9M)	1.8M	(85.2M)	(80.9M)
Retained Earnings	(1.4M)	(36.3M)	(53.1M)	(54.5M)	(63.9M)	(60.7M)
Cash	10.9M	15.1M	21.9M	7.9M	85.2M	43.8M
Non Current Assets Total	28.5M	1.6M	55.4K	(272.1K)	402.9K	382.8K
Non Currrent Assets Other	25.2M	(30.2M)	177.0K	(20.7M)	(141.6M)	(134.5M)
Cash And Short Term Investments	10.9M	15.1M	21.9M	7.9M	85.2M	43.8M
Net Receivables	37.8M	10.4M	20.0M	7.7M	56.3M	59.1M
Liabilities And Stockholders Equity	78.4M	31.7M	50.7M	20.5M	142.0M	86.9M
Other Current Assets	39.0B	592.8K	885.9K	3.4M	56.7M	53.8M
Other Stockholder Equity	58.5M	56.6M	56.6M	67.0M	206.3M	216.7M
Total Liab	30.3M	14.4M	38.4M	11.6M	3.6M	3.4M
Total Current Assets	49.9M	30.1M	50.6M	20.7M	142.0M	72.4M
Accumulated Other Comprehensive Income	(7.0M)	(3.1M)	(1.6M)	(3.8M)	(4.1M)	(3.9M)
Common Stock	5.0K	5.0K	5.0K	7.0K	43.8K	46.0K
Net Tangible Assets	48.1M	17.3M	12.3M	8.7M	7.9M	7.5M
Non Current Liabilities Total	20.1M	4.4M	0.0	11.6M	3.2M	3.0M
Net Invested Capital	68.1M	27.3M	12.3M	8.7M	138.4M	145.3M
Net Working Capital	39.8M	15.7M	12.2M	9.1M	138.4M	145.3M
Property Plant Equipment	1.3M	763.6K	66.9K	55.4K	49.9K	47.4K
Inventory	(39.0B)	(14.4M)	7.8M	1.7M	191.2K	200.8K

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:

How To Invest In Akso

Details

Is Akso Stock a good investment?

Details

What is Akso Health's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.21)

Revenue Per Share

0.051

Quarterly Revenue Growth

0.148

Return On Assets

(0.07)

Return On Equity

(0.12)

The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Akso Cost Of Revenue vs Total Revenue Analysis

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Total Revenue

Akso Health fundamental ratios Correlations

Akso Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Akso Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Liab	+ 1.0	Intangible Assets
Common Stock	+ 0.99	Common Stock Shares Outstanding
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding
Total Current Assets	+ 0.96	Cash
Total Current Assets	+ 0.96	Cash And Short Term Investments

Common Stock	- 0.96	Non Currrent Assets Other
Other Liab	- 0.95	Common Stock
Intangible Assets	- 0.95	Common Stock
Cash And Short Term Investments	- 0.95	Net Debt
Cash	- 0.95	Net Debt
Non Currrent Assets Other	- 0.95	Common Stock Shares Outstanding